Oversold Conditions For ImmunoGen (IMGN)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100. A stock is considered to be oversold if the RSI reading falls below 30.

In trading on Wednesday, shares of ImmunoGen, Inc. ( IMGN) entered into oversold territory, hitting an RSI reading of 28.7, after changing hands as low as $5.065 per share. By comparison, the current RSI reading of the S&P 500 ETF (SPY) is 58.1. A bullish investor could look at IMGN's 28.7 RSI reading today as a sign that the recent heavy selling is in the process of exhausting itself, and begin to look for entry point opportunities on the buy side. The chart below shows the one year performance of IMGN shares:

START SLIDESHOW:
Find out what 9 other oversold stocks you need to know about »

ImmunoGen, Inc. 1 Year Performance Chart

Looking at the chart above, IMGN's low point in its 52 week range is $1.51 per share, with $8.84 as the 52 week high point — that compares with a last trade of $5.22.

More from Stocks

Netflix, IBM, Legal Pot in Canada, Mega Millions - 5 Things You Must Know

Netflix, IBM, Legal Pot in Canada, Mega Millions - 5 Things You Must Know

The Good Side of Bad Selloffs

The Good Side of Bad Selloffs

Jim Cramer: The Bulls Won the Night on Tuesday

Jim Cramer: The Bulls Won the Night on Tuesday

A Guide to Investing in the Fast-Emerging Cannabis Industry

A Guide to Investing in the Fast-Emerging Cannabis Industry

Chart of the Day: Can Disney Catch Netflix?

Chart of the Day: Can Disney Catch Netflix?